bioRxivMolecular BiologyPreprint
PRC2-binding regions are hotspots of DNA methylation entropy in pre-cancer and cancer
Djansel BukoveciD, Monika Simjanoska Misheva, Marija GjorgjievskaiD, Goran KungulovskiiD
Abstract
DNA methylation aberrations and variability are pervasive features of cancer, yet their relationship with chromatin regulation remains incompletely understood. Across hundreds of matched tumor-normal methylomes, regions with the highest methylation entropy in both tumor and normal tissues were consistently enriched for PRC2-associated factors. In tumors, inter-sample methylation variability was increased across the full range of PRC2-associated levels, while mean methylation progressively increased from low- to high-PRC2-binding regions; this gradient was substantially weaker in matched normal tissues. PRC2-associated regions with higher DNA methylation levels were preferentially associated with poised and repressed chromatin states, reduced chromatin accessibility, and reduced gene expression. Independent normal-precancer-cancer cohorts showed that this PRC2-associated methylation state emerges early, with precancerous and malignant tissues displaying highly similar profiles that are distinct from those of healthy tissues. Single-cell colon cancer methylomes independently confirmed increased methylation entropy at PRC2 regions. Higher PRC2-region entropy was associated with scores reflecting hypoxic states, aggressive tumor features, and poorer survival outcomes. Collectively, these findings identify PRC2-binding regions as hotspots of DNA methylation variability that become dysregulated during tumorigenesis.
- organism: human
- assay: DNA methylation
- research focus: differential expression
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Transcription factors overcome the repressive impact of Polycomb-associated methylation in tumors
Min-Kyeong Kwon, Goeun Park, … Sun Shim Choi·bioRxiv·May 15, 2025
- DNA methylation variability defines a fundamental dimension of tumor epigenomes linked to genomic instability, tumor aggressiveness, and clinical outcomes
Djansel Bukovec, Blagojche Gjorgjioski, … Goran Kungulovski·Epigenetics & ChromatinPeer-reviewed·Sep 29, 2026
- DNA methylation landscapes in human cells and their chromatin determinants
Wei Cui, Zhijun Huang, Gerd P. Pfeifer·Ageing and Cancer Research & TreatmentPeer-reviewed·Dec 18, 2025
- De-novo DNA Methylation of Bivalent Promoters Induces Gene Activation through PRC2 Displacement
Henriette O’Geen, Alina Mihalovits, … Markéta Tomková·bioRxiv·Feb 7, 2025
- Distinct chromatin signatures of DNA hypomethylation in aging and cancer
Raúl F. Pérez, Juan Ramón Tejedor, … Mario F. Fraga·Aging CellPeer-reviewed·Mar 5, 2018
- Systematic identification of regions where DNA methylation is correlated with transcription refines regulatory logic in normal and tumour tissues
Richard Heery, Martin H. Schaefer·Nucleic Acids ResearchPeer-reviewed·Sep 23, 2025